Recent News for AKRO - Akero Therapeutics, Inc.

Date Title
Jan 17 Akero Therapeutics (AKRO) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
Jan 13 Akero Therapeutics Expands Phase 2a Trial in NASH to Include Cohort of Cirrhotic Patients
Jan 8 Akero Therapeutics To Present At The 2020 J.P. Morgan Healthcare Conference
Jan 2 63 Biggest Movers From Tuesday
Dec 31 Mid-Afternoon Market Update: Dow Falls 40 Points; Core Laboratories Shares Slide
Dec 31 FCEL, PLX, CLB and SAVA among midday movers
Dec 31 Mid-Day Market Update: Neovasc Jumps After Submitting Approval Application For Neovasc Reducer; EyeGate Pharmaceuticals Shares Plummet
Dec 31 Healthcare - Top 5 Gainers / Losers
Dec 19 4 More Biotechs With Blockbuster Potential
Dec 16 Akero Therapeutics Completes Enrollment in Phase 2a Study in NASH
Dec 15 Hedge Funds Are Dumping Akero Therapeutics, Inc. (AKRO)
Nov 13 Akero Therapeutics to Present at the Jefferies 2019 London Healthcare Conference
Nov 12 Akero Therapeutics EPS misses by $0.14
Nov 12 Akero Therapeutics Reports Recent Highlights and Third Quarter 2019 Financial Results
Nov 4 InSphero Wins Sino-European Innovation Award for Breakthrough NASH Discovery and Safety Testing Platform
Oct 31 Hedge Funds Have Never Been This Bullish On Akero Therapeutics, Inc. (AKRO)
Sep 19 Does Akero Therapeutics, Inc. (NASDAQ:AKRO) Need To Raise More Cash?
Sep 4 Akero Therapeutics To Present At The Morgan Stanley 17th Annual Global Healthcare Conference
Aug 12 Akero Therapeutics EPS misses by $1.76
Aug 12 Akero Therapeutics Reports Recent Highlights and Second Quarter 2019 Financial Results
Aug 8 Stocks That Set New 52-Week Highs Thursday
Aug 8 The Daily Biotech Pulse: Glaukos To Buy Avedro, Mixed Adcom Vote For Gilead, Dynavax Offering

Back to the Main AKRO Page...